Document Detail


Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.
MedLine Citation:
PMID:  20496178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neuroimmune pharmacology (NIP) can be considered a multidisciplinary science where areas of neuroscience, immunology, and pharmacology intersect in neurological disorders. The R25 training program titled "Translational Research in NeuroAIDS and Mental Health (TR-NAMH): An innovative mentoring program to promote diversity in NeuroAIDS Research (R25 MH080661)" at the Johns Hopkins University is a web-based interactive course with the goal to improve the capacity of high quality research by developing mentoring programs for (1) doctoral and postdoctoral candidates and junior faculty from racial and ethnic minorities and (2) non-minority individuals at the same levels, whose research focuses on NeuroAIDS disparity issues such as HIV-associated neurocognitive disorders (HAND). This web-based interactive course overcomes the limitations of traditional education such as access to expert faculty and financial burden of scientists from racial and ethnic minority groups in the field of NeuroAIDS research and NIP and identifies rich nurturing environments for investigators to support their careers. The TR-NAMH program identifies a cadre of talented students and investigators eager to commit to innovative educational and training sessions in NeuroAIDS and NIP. The interplay between NIP changes precipitated by HIV infection in the brain makes the study of HAND an outstanding way to integrate important concepts from these two fields. The course includes activities besides those related to didactic learning such as research training and long-term mentoring; hence, the newly learned topics in NIP are continually reinforced and implemented in real-time experiences. We describe how NIP is integrated in the TR-NAMH program in the context of HAND.
Authors:
Amanda Brown; Bruce Shiramizu; Avindra Nath; Valerie Wojna
Related Documents :
7309398 - Learning about rehabilitation.
21942128 - Epidemic management: a caribbean university's response to the 2009 h1n1 outbreak.
18808458 - University of life or academia? a review of community matrons/case managers continuing ...
15788038 - A survey of trainees' opinions and current clinical practice after behaviour therapy tr...
18978628 - An intensive combined training program modulates physical, physiological, biomotoric, a...
20844128 - Rule-based learning explains visual perceptual learning and its specificity and transfer.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-05-25
Journal Detail:
Title:  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology     Volume:  6     ISSN:  1557-1904     ISO Abbreviation:  J Neuroimmune Pharmacol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-01-28     Completed Date:  2011-05-09     Revised Date:  2013-06-17    
Medline Journal Info:
Nlm Unique ID:  101256586     Medline TA:  J Neuroimmune Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  80-8     Citation Subset:  IM    
Affiliation:
Department of Neurology, Division of Neuroimmunology and Neurological Infections, Johns Hopkins University, Baltimore, MD 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AIDS Dementia Complex*
Allergy and Immunology / education
Education, Distance / methods*
Education, Medical, Graduate / methods*
Humans
Internet
Mentors
Minority Groups
Neurosciences / education
Pharmacology / education
Translational Medical Research / education*
Grant Support
ID/Acronym/Agency:
G12RR03051/RR/NCRR NIH HHS; P20RR011091/RR/NCRR NIH HHS; R25 MH080661/MH/NIMH NIH HHS; R25 MH080661-03/MH/NIMH NIH HHS; U19 MH081835-03/MH/NIMH NIH HHS; U19MH081835/MH/NIMH NIH HHS; U54 NS043011/NS/NINDS NIH HHS; U54 NS043011-01/NS/NINDS NIH HHS; U54 NS043011-07S1/NS/NINDS NIH HHS; U54 NS043049-05/NS/NINDS NIH HHS; U54 NS056883/NS/NINDS NIH HHS; U54 NS056883-03/NS/NINDS NIH HHS; U54 NS43011/NS/NINDS NIH HHS; U54 NS56883/NS/NINDS NIH HHS; U54NS043049/NS/NINDS NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral ...
Next Document:  Celecoxib increases retinoid sensitivity in human colon cancer cell lines.